Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perks of Methylprednisolone for Hospitalized COVID-19 Patients: A Clinical Trial

NCT04559113 is registered in ClinicalTrials.gov with Lahore General Hospital as lead sponsor.

NCT NCT04559113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04559113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perks of Methylprednisolone for Hospitalized COVID-19 Patients: A Clinical Trial
Lead sponsor
Lahore General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 1, 2020
Completion date
December 30, 2020
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars (severe acute respiratory syndrome), sars-cov infection